Boxer Capital Management, LLC, by Aaron I Davis, Managing Member
@Boxer Capital, Llc
Latest period2024 - Q3ReportedManaged Assets$2.038BTotal holdings68
Assets growth rate7.32%Assets growth rate (2-Q avg)0.55%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Boxer Capital, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 68 positions.
Assets under management
The assets under management (AUM) of Boxer Capital, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 2.038B in assets, with a quarterly growth rate of 7.32% and a 2-quarter average growth rate of 0.55%. The portfolio is managed by Boxer Capital Management, LLC, by Aaron I Davis, Managing Member, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
RVMDRevolution Medicines Inc
| 9.53% | $194.074M 4.279M shares@ $45.35 avg price | |
TYRATyra Biosciences Inc
| 7.44% | $151.601M 6.448M shares@ $23.51 avg price | |
NUVLNuvalent Inc
| 5.63% | $114.596M 1.12M shares@ $102.31 avg price | |
BGNEBeigene Ltd
| 5.51% | $112.255M 500,000 shares@ $224.51 avg price | |
CYTKCytokinetics Inc
| 5.45% | $110.88M 2.1M shares@ $52.8 avg price | |
SWTXSpringworks Therapeutics Inc
| 5.38% | $109.626M 3.422M shares@ $32.05 avg price | |
MRUSMerus N V
| 4.66% | $94.924M 1.9M shares@ $49.96 avg price | |
SRPTSarepta Therapeutics Inc
| 3.99% | $81.178M 650,000 shares@ $124.89 avg price | |
RNAAvidity Biosciences Inc
| 3.9% | $79.339M 1.727M shares@ $45.94 avg price | |
IDYAIdeaya Biosciences Inc
| 3.43% | $69.785M 2.203M shares@ $31.68 avg price |